nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—breast cancer—bone cancer	0.159	0.431	CtDrD
Paclitaxel—TUBB4B—bone cancer	0.135	0.402	CbGaD
Paclitaxel—TUBB2A—bone cancer	0.112	0.333	CbGaD
Paclitaxel—kidney cancer—bone cancer	0.107	0.29	CtDrD
Paclitaxel—lung cancer—bone cancer	0.103	0.28	CtDrD
Paclitaxel—NR1I2—bone cancer	0.0742	0.22	CbGaD
Paclitaxel—ABCC10—Doxorubicin—bone cancer	0.0207	0.119	CbGbCtD
Paclitaxel—ABCC10—Methotrexate—bone cancer	0.02	0.115	CbGbCtD
Paclitaxel—ABCC1—Epirubicin—bone cancer	0.015	0.0861	CbGbCtD
Paclitaxel—CYP3A4—bone cancer	0.0147	0.0437	CbGaD
Paclitaxel—ABCB11—Doxorubicin—bone cancer	0.0112	0.0644	CbGbCtD
Paclitaxel—CYP1B1—Doxorubicin—bone cancer	0.0112	0.0644	CbGbCtD
Paclitaxel—SLCO1B3—Methotrexate—bone cancer	0.0112	0.0641	CbGbCtD
Paclitaxel—ABCC2—Carboplatin—bone cancer	0.0103	0.0592	CbGbCtD
Paclitaxel—ABCG2—Carboplatin—bone cancer	0.00933	0.0535	CbGbCtD
Paclitaxel—ABCC2—Cisplatin—bone cancer	0.00882	0.0506	CbGbCtD
Paclitaxel—ABCC1—Doxorubicin—bone cancer	0.00798	0.0458	CbGbCtD
Paclitaxel—ABCG2—Cisplatin—bone cancer	0.00797	0.0457	CbGbCtD
Paclitaxel—ABCC1—Methotrexate—bone cancer	0.00773	0.0443	CbGbCtD
Paclitaxel—ABCC2—Doxorubicin—bone cancer	0.00591	0.0339	CbGbCtD
Paclitaxel—ABCC2—Methotrexate—bone cancer	0.00572	0.0328	CbGbCtD
Paclitaxel—ABCG2—Doxorubicin—bone cancer	0.00534	0.0306	CbGbCtD
Paclitaxel—ABCG2—Methotrexate—bone cancer	0.00517	0.0297	CbGbCtD
Paclitaxel—CYP2C9—Cisplatin—bone cancer	0.00296	0.017	CbGbCtD
Paclitaxel—ABCB1—Cisplatin—bone cancer	0.00287	0.0165	CbGbCtD
Paclitaxel—ABCB1—Doxorubicin—bone cancer	0.00193	0.011	CbGbCtD
Paclitaxel—ABCB1—Methotrexate—bone cancer	0.00187	0.0107	CbGbCtD
Paclitaxel—CYP3A4—Doxorubicin—bone cancer	0.00115	0.00662	CbGbCtD
Paclitaxel—Cabazitaxel—TUBB4B—bone cancer	0.000798	0.239	CrCbGaD
Paclitaxel—Cabazitaxel—TUBB2A—bone cancer	0.000661	0.198	CrCbGaD
Paclitaxel—Docetaxel—TUBB4B—bone cancer	0.000644	0.193	CrCbGaD
Paclitaxel—Docetaxel—TUBB2A—bone cancer	0.000534	0.16	CrCbGaD
Paclitaxel—Docetaxel—NR1I2—bone cancer	0.000353	0.106	CrCbGaD
Paclitaxel—Docetaxel—EGFR—bone cancer	0.000191	0.0573	CrCbGaD
Paclitaxel—Cabazitaxel—CYP3A4—bone cancer	8.65e-05	0.0259	CrCbGaD
Paclitaxel—Docetaxel—CYP3A4—bone cancer	6.99e-05	0.0209	CrCbGaD
Paclitaxel—MAP4—connective tissue—bone cancer	6.2e-05	0.0513	CbGeAlD
Paclitaxel—TUBB3—connective tissue—bone cancer	6.2e-05	0.0513	CbGeAlD
Paclitaxel—BCL2—connective tissue—bone cancer	5.64e-05	0.0467	CbGeAlD
Paclitaxel—MAPT—tendon—bone cancer	5.42e-05	0.0449	CbGeAlD
Paclitaxel—MAPT—spinal cord—bone cancer	5.23e-05	0.0433	CbGeAlD
Paclitaxel—MAP4—tendon—bone cancer	4.26e-05	0.0353	CbGeAlD
Paclitaxel—MAP4—spinal cord—bone cancer	4.11e-05	0.034	CbGeAlD
Paclitaxel—TUBB1—bone marrow—bone cancer	4.04e-05	0.0334	CbGeAlD
Paclitaxel—TUBB4A—connective tissue—bone cancer	3.78e-05	0.0312	CbGeAlD
Paclitaxel—BCL2—bone marrow—bone cancer	3.75e-05	0.0311	CbGeAlD
Paclitaxel—TUBB2B—connective tissue—bone cancer	3.65e-05	0.0302	CbGeAlD
Paclitaxel—TUBB2A—connective tissue—bone cancer	3.43e-05	0.0284	CbGeAlD
Paclitaxel—MAP2—tendon—bone cancer	3.36e-05	0.0278	CbGeAlD
Paclitaxel—MAP2—spinal cord—bone cancer	3.24e-05	0.0268	CbGeAlD
Paclitaxel—Haemoglobin—Epirubicin—bone cancer	3.02e-05	0.000513	CcSEcCtD
Paclitaxel—Stomatitis—Doxorubicin—bone cancer	3.01e-05	0.000513	CcSEcCtD
Paclitaxel—Rhinitis—Epirubicin—bone cancer	3.01e-05	0.000512	CcSEcCtD
Paclitaxel—Urinary tract infection—Doxorubicin—bone cancer	3.01e-05	0.000511	CcSEcCtD
Paclitaxel—Conjunctivitis—Doxorubicin—bone cancer	3.01e-05	0.000511	CcSEcCtD
Paclitaxel—Haemorrhage—Epirubicin—bone cancer	3e-05	0.00051	CcSEcCtD
Paclitaxel—Eye disorder—Methotrexate—bone cancer	3e-05	0.00051	CcSEcCtD
Paclitaxel—Tinnitus—Methotrexate—bone cancer	2.99e-05	0.000508	CcSEcCtD
Paclitaxel—Hypoaesthesia—Epirubicin—bone cancer	2.99e-05	0.000508	CcSEcCtD
Paclitaxel—Asthenia—Cisplatin—bone cancer	2.98e-05	0.000506	CcSEcCtD
Paclitaxel—Pharyngitis—Epirubicin—bone cancer	2.98e-05	0.000506	CcSEcCtD
Paclitaxel—Cardiac disorder—Methotrexate—bone cancer	2.98e-05	0.000506	CcSEcCtD
Paclitaxel—Urinary tract disorder—Epirubicin—bone cancer	2.96e-05	0.000504	CcSEcCtD
Paclitaxel—Oedema peripheral—Epirubicin—bone cancer	2.96e-05	0.000503	CcSEcCtD
Paclitaxel—Haematuria—Doxorubicin—bone cancer	2.95e-05	0.000501	CcSEcCtD
Paclitaxel—Connective tissue disorder—Epirubicin—bone cancer	2.95e-05	0.000501	CcSEcCtD
Paclitaxel—TUBB4B—connective tissue—bone cancer	2.94e-05	0.0244	CbGeAlD
Paclitaxel—Urethral disorder—Epirubicin—bone cancer	2.94e-05	0.0005	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Doxorubicin—bone cancer	2.93e-05	0.000497	CcSEcCtD
Paclitaxel—Epistaxis—Doxorubicin—bone cancer	2.92e-05	0.000496	CcSEcCtD
Paclitaxel—Angiopathy—Methotrexate—bone cancer	2.91e-05	0.000495	CcSEcCtD
Paclitaxel—Sinusitis—Doxorubicin—bone cancer	2.9e-05	0.000493	CcSEcCtD
Paclitaxel—Immune system disorder—Methotrexate—bone cancer	2.9e-05	0.000492	CcSEcCtD
Paclitaxel—Visual impairment—Epirubicin—bone cancer	2.89e-05	0.000492	CcSEcCtD
Paclitaxel—Mediastinal disorder—Methotrexate—bone cancer	2.89e-05	0.000491	CcSEcCtD
Paclitaxel—Chills—Methotrexate—bone cancer	2.88e-05	0.000489	CcSEcCtD
Paclitaxel—Diarrhoea—Cisplatin—bone cancer	2.84e-05	0.000483	CcSEcCtD
Paclitaxel—Erythema multiforme—Epirubicin—bone cancer	2.84e-05	0.000482	CcSEcCtD
Paclitaxel—Alopecia—Methotrexate—bone cancer	2.83e-05	0.000482	CcSEcCtD
Paclitaxel—Bradycardia—Doxorubicin—bone cancer	2.83e-05	0.000481	CcSEcCtD
Paclitaxel—Mental disorder—Methotrexate—bone cancer	2.81e-05	0.000478	CcSEcCtD
Paclitaxel—Eye disorder—Epirubicin—bone cancer	2.8e-05	0.000477	CcSEcCtD
Paclitaxel—Tinnitus—Epirubicin—bone cancer	2.8e-05	0.000476	CcSEcCtD
Paclitaxel—Erythema—Methotrexate—bone cancer	2.79e-05	0.000475	CcSEcCtD
Paclitaxel—Malnutrition—Methotrexate—bone cancer	2.79e-05	0.000475	CcSEcCtD
Paclitaxel—Haemoglobin—Doxorubicin—bone cancer	2.79e-05	0.000475	CcSEcCtD
Paclitaxel—Cardiac disorder—Epirubicin—bone cancer	2.79e-05	0.000474	CcSEcCtD
Paclitaxel—Flushing—Epirubicin—bone cancer	2.79e-05	0.000474	CcSEcCtD
Paclitaxel—Rhinitis—Doxorubicin—bone cancer	2.78e-05	0.000473	CcSEcCtD
Paclitaxel—Haemorrhage—Doxorubicin—bone cancer	2.78e-05	0.000472	CcSEcCtD
Paclitaxel—Hypoaesthesia—Doxorubicin—bone cancer	2.76e-05	0.00047	CcSEcCtD
Paclitaxel—Pharyngitis—Doxorubicin—bone cancer	2.76e-05	0.000469	CcSEcCtD
Paclitaxel—Urinary tract disorder—Doxorubicin—bone cancer	2.74e-05	0.000466	CcSEcCtD
Paclitaxel—Oedema peripheral—Doxorubicin—bone cancer	2.74e-05	0.000465	CcSEcCtD
Paclitaxel—Dysgeusia—Methotrexate—bone cancer	2.73e-05	0.000465	CcSEcCtD
Paclitaxel—Connective tissue disorder—Doxorubicin—bone cancer	2.73e-05	0.000464	CcSEcCtD
Paclitaxel—Angiopathy—Epirubicin—bone cancer	2.72e-05	0.000463	CcSEcCtD
Paclitaxel—Urethral disorder—Doxorubicin—bone cancer	2.72e-05	0.000463	CcSEcCtD
Paclitaxel—Immune system disorder—Epirubicin—bone cancer	2.71e-05	0.000461	CcSEcCtD
Paclitaxel—Mediastinal disorder—Epirubicin—bone cancer	2.7e-05	0.00046	CcSEcCtD
Paclitaxel—Back pain—Methotrexate—bone cancer	2.7e-05	0.000459	CcSEcCtD
Paclitaxel—Chills—Epirubicin—bone cancer	2.69e-05	0.000458	CcSEcCtD
Paclitaxel—Arrhythmia—Epirubicin—bone cancer	2.68e-05	0.000456	CcSEcCtD
Paclitaxel—Visual impairment—Doxorubicin—bone cancer	2.68e-05	0.000455	CcSEcCtD
Paclitaxel—Alopecia—Epirubicin—bone cancer	2.65e-05	0.000451	CcSEcCtD
Paclitaxel—Vomiting—Cisplatin—bone cancer	2.64e-05	0.000449	CcSEcCtD
Paclitaxel—Vision blurred—Methotrexate—bone cancer	2.63e-05	0.000447	CcSEcCtD
Paclitaxel—Mental disorder—Epirubicin—bone cancer	2.63e-05	0.000447	CcSEcCtD
Paclitaxel—Erythema multiforme—Doxorubicin—bone cancer	2.63e-05	0.000446	CcSEcCtD
Paclitaxel—Rash—Cisplatin—bone cancer	2.62e-05	0.000445	CcSEcCtD
Paclitaxel—Dermatitis—Cisplatin—bone cancer	2.62e-05	0.000445	CcSEcCtD
Paclitaxel—Malnutrition—Epirubicin—bone cancer	2.61e-05	0.000444	CcSEcCtD
Paclitaxel—Erythema—Epirubicin—bone cancer	2.61e-05	0.000444	CcSEcCtD
Paclitaxel—TUBB4A—tendon—bone cancer	2.59e-05	0.0215	CbGeAlD
Paclitaxel—Eye disorder—Doxorubicin—bone cancer	2.59e-05	0.000441	CcSEcCtD
Paclitaxel—Ill-defined disorder—Methotrexate—bone cancer	2.59e-05	0.00044	CcSEcCtD
Paclitaxel—Tinnitus—Doxorubicin—bone cancer	2.59e-05	0.00044	CcSEcCtD
Paclitaxel—Anaemia—Methotrexate—bone cancer	2.58e-05	0.000439	CcSEcCtD
Paclitaxel—Cardiac disorder—Doxorubicin—bone cancer	2.58e-05	0.000438	CcSEcCtD
Paclitaxel—Flushing—Doxorubicin—bone cancer	2.58e-05	0.000438	CcSEcCtD
Paclitaxel—Flatulence—Epirubicin—bone cancer	2.57e-05	0.000438	CcSEcCtD
Paclitaxel—Tension—Epirubicin—bone cancer	2.56e-05	0.000436	CcSEcCtD
Paclitaxel—Dysgeusia—Epirubicin—bone cancer	2.56e-05	0.000435	CcSEcCtD
Paclitaxel—Nervousness—Epirubicin—bone cancer	2.54e-05	0.000431	CcSEcCtD
Paclitaxel—Back pain—Epirubicin—bone cancer	2.53e-05	0.00043	CcSEcCtD
Paclitaxel—Angiopathy—Doxorubicin—bone cancer	2.52e-05	0.000428	CcSEcCtD
Paclitaxel—Malaise—Methotrexate—bone cancer	2.52e-05	0.000428	CcSEcCtD
Paclitaxel—Muscle spasms—Epirubicin—bone cancer	2.51e-05	0.000427	CcSEcCtD
Paclitaxel—Immune system disorder—Doxorubicin—bone cancer	2.51e-05	0.000426	CcSEcCtD
Paclitaxel—TUBB2B—tendon—bone cancer	2.51e-05	0.0207	CbGeAlD
Paclitaxel—Vertigo—Methotrexate—bone cancer	2.51e-05	0.000426	CcSEcCtD
Paclitaxel—TUBB4A—spinal cord—bone cancer	2.5e-05	0.0207	CbGeAlD
Paclitaxel—Mediastinal disorder—Doxorubicin—bone cancer	2.5e-05	0.000426	CcSEcCtD
Paclitaxel—Leukopenia—Methotrexate—bone cancer	2.5e-05	0.000425	CcSEcCtD
Paclitaxel—CYP19A1—connective tissue—bone cancer	2.49e-05	0.0206	CbGeAlD
Paclitaxel—Chills—Doxorubicin—bone cancer	2.49e-05	0.000424	CcSEcCtD
Paclitaxel—Arrhythmia—Doxorubicin—bone cancer	2.48e-05	0.000422	CcSEcCtD
Paclitaxel—Nausea—Cisplatin—bone cancer	2.47e-05	0.000419	CcSEcCtD
Paclitaxel—Vision blurred—Epirubicin—bone cancer	2.46e-05	0.000419	CcSEcCtD
Paclitaxel—Alopecia—Doxorubicin—bone cancer	2.45e-05	0.000417	CcSEcCtD
Paclitaxel—Cough—Methotrexate—bone cancer	2.44e-05	0.000414	CcSEcCtD
Paclitaxel—Mental disorder—Doxorubicin—bone cancer	2.43e-05	0.000414	CcSEcCtD
Paclitaxel—Ill-defined disorder—Epirubicin—bone cancer	2.42e-05	0.000412	CcSEcCtD
Paclitaxel—TUBB2B—spinal cord—bone cancer	2.42e-05	0.02	CbGeAlD
Paclitaxel—Convulsion—Methotrexate—bone cancer	2.42e-05	0.000411	CcSEcCtD
Paclitaxel—Erythema—Doxorubicin—bone cancer	2.42e-05	0.000411	CcSEcCtD
Paclitaxel—Malnutrition—Doxorubicin—bone cancer	2.42e-05	0.000411	CcSEcCtD
Paclitaxel—Anaemia—Epirubicin—bone cancer	2.41e-05	0.000411	CcSEcCtD
Paclitaxel—Agitation—Epirubicin—bone cancer	2.4e-05	0.000408	CcSEcCtD
Paclitaxel—Flatulence—Doxorubicin—bone cancer	2.38e-05	0.000405	CcSEcCtD
Paclitaxel—Chest pain—Methotrexate—bone cancer	2.38e-05	0.000404	CcSEcCtD
Paclitaxel—Myalgia—Methotrexate—bone cancer	2.38e-05	0.000404	CcSEcCtD
Paclitaxel—Arthralgia—Methotrexate—bone cancer	2.38e-05	0.000404	CcSEcCtD
Paclitaxel—TUBB—tendon—bone cancer	2.37e-05	0.0196	CbGeAlD
Paclitaxel—Tension—Doxorubicin—bone cancer	2.37e-05	0.000403	CcSEcCtD
Paclitaxel—Dysgeusia—Doxorubicin—bone cancer	2.37e-05	0.000402	CcSEcCtD
Paclitaxel—TUBB2A—tendon—bone cancer	2.36e-05	0.0195	CbGeAlD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	2.36e-05	0.000401	CcSEcCtD
Paclitaxel—Malaise—Epirubicin—bone cancer	2.36e-05	0.000401	CcSEcCtD
Paclitaxel—Discomfort—Methotrexate—bone cancer	2.35e-05	0.000399	CcSEcCtD
Paclitaxel—Nervousness—Doxorubicin—bone cancer	2.35e-05	0.000399	CcSEcCtD
Paclitaxel—Vertigo—Epirubicin—bone cancer	2.35e-05	0.000399	CcSEcCtD
Paclitaxel—Syncope—Epirubicin—bone cancer	2.34e-05	0.000398	CcSEcCtD
Paclitaxel—Leukopenia—Epirubicin—bone cancer	2.34e-05	0.000398	CcSEcCtD
Paclitaxel—Back pain—Doxorubicin—bone cancer	2.34e-05	0.000398	CcSEcCtD
Paclitaxel—CYP1B1—connective tissue—bone cancer	2.33e-05	0.0193	CbGeAlD
Paclitaxel—TUBB6—tendon—bone cancer	2.33e-05	0.0193	CbGeAlD
Paclitaxel—Muscle spasms—Doxorubicin—bone cancer	2.32e-05	0.000395	CcSEcCtD
Paclitaxel—Palpitations—Epirubicin—bone cancer	2.31e-05	0.000393	CcSEcCtD
Paclitaxel—TUBB—bone marrow—bone cancer	2.3e-05	0.019	CbGeAlD
Paclitaxel—Confusional state—Methotrexate—bone cancer	2.3e-05	0.000391	CcSEcCtD
Paclitaxel—Loss of consciousness—Epirubicin—bone cancer	2.3e-05	0.00039	CcSEcCtD
Paclitaxel—TUBB—spinal cord—bone cancer	2.29e-05	0.0189	CbGeAlD
Paclitaxel—TUBB2A—bone marrow—bone cancer	2.29e-05	0.0189	CbGeAlD
Paclitaxel—Cough—Epirubicin—bone cancer	2.28e-05	0.000388	CcSEcCtD
Paclitaxel—Anaphylactic shock—Methotrexate—bone cancer	2.28e-05	0.000387	CcSEcCtD
Paclitaxel—Vision blurred—Doxorubicin—bone cancer	2.28e-05	0.000387	CcSEcCtD
Paclitaxel—TUBB2A—spinal cord—bone cancer	2.28e-05	0.0188	CbGeAlD
Paclitaxel—Convulsion—Epirubicin—bone cancer	2.26e-05	0.000385	CcSEcCtD
Paclitaxel—Infection—Methotrexate—bone cancer	2.26e-05	0.000385	CcSEcCtD
Paclitaxel—TUBB6—bone marrow—bone cancer	2.26e-05	0.0187	CbGeAlD
Paclitaxel—Hypertension—Epirubicin—bone cancer	2.26e-05	0.000383	CcSEcCtD
Paclitaxel—TUBB6—spinal cord—bone cancer	2.25e-05	0.0186	CbGeAlD
Paclitaxel—Ill-defined disorder—Doxorubicin—bone cancer	2.24e-05	0.000381	CcSEcCtD
Paclitaxel—Nervous system disorder—Methotrexate—bone cancer	2.23e-05	0.00038	CcSEcCtD
Paclitaxel—Anaemia—Doxorubicin—bone cancer	2.23e-05	0.00038	CcSEcCtD
Paclitaxel—Thrombocytopenia—Methotrexate—bone cancer	2.23e-05	0.000379	CcSEcCtD
Paclitaxel—Arthralgia—Epirubicin—bone cancer	2.22e-05	0.000378	CcSEcCtD
Paclitaxel—Chest pain—Epirubicin—bone cancer	2.22e-05	0.000378	CcSEcCtD
Paclitaxel—Myalgia—Epirubicin—bone cancer	2.22e-05	0.000378	CcSEcCtD
Paclitaxel—Agitation—Doxorubicin—bone cancer	2.22e-05	0.000378	CcSEcCtD
Paclitaxel—Anxiety—Epirubicin—bone cancer	2.22e-05	0.000377	CcSEcCtD
Paclitaxel—Skin disorder—Methotrexate—bone cancer	2.21e-05	0.000376	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	2.21e-05	0.000376	CcSEcCtD
Paclitaxel—Hyperhidrosis—Methotrexate—bone cancer	2.2e-05	0.000374	CcSEcCtD
Paclitaxel—Discomfort—Epirubicin—bone cancer	2.2e-05	0.000374	CcSEcCtD
Paclitaxel—Malaise—Doxorubicin—bone cancer	2.18e-05	0.000371	CcSEcCtD
Paclitaxel—Dry mouth—Epirubicin—bone cancer	2.18e-05	0.00037	CcSEcCtD
Paclitaxel—Vertigo—Doxorubicin—bone cancer	2.17e-05	0.000369	CcSEcCtD
Paclitaxel—Anorexia—Methotrexate—bone cancer	2.17e-05	0.000369	CcSEcCtD
Paclitaxel—Syncope—Doxorubicin—bone cancer	2.17e-05	0.000369	CcSEcCtD
Paclitaxel—Leukopenia—Doxorubicin—bone cancer	2.16e-05	0.000368	CcSEcCtD
Paclitaxel—Confusional state—Epirubicin—bone cancer	2.15e-05	0.000366	CcSEcCtD
Paclitaxel—Palpitations—Doxorubicin—bone cancer	2.14e-05	0.000363	CcSEcCtD
Paclitaxel—Oedema—Epirubicin—bone cancer	2.13e-05	0.000363	CcSEcCtD
Paclitaxel—Anaphylactic shock—Epirubicin—bone cancer	2.13e-05	0.000363	CcSEcCtD
Paclitaxel—Hypotension—Methotrexate—bone cancer	2.13e-05	0.000362	CcSEcCtD
Paclitaxel—Loss of consciousness—Doxorubicin—bone cancer	2.12e-05	0.000361	CcSEcCtD
Paclitaxel—Infection—Epirubicin—bone cancer	2.12e-05	0.00036	CcSEcCtD
Paclitaxel—Cough—Doxorubicin—bone cancer	2.11e-05	0.000359	CcSEcCtD
Paclitaxel—Shock—Epirubicin—bone cancer	2.1e-05	0.000357	CcSEcCtD
Paclitaxel—Convulsion—Doxorubicin—bone cancer	2.09e-05	0.000356	CcSEcCtD
Paclitaxel—Nervous system disorder—Epirubicin—bone cancer	2.09e-05	0.000356	CcSEcCtD
Paclitaxel—Thrombocytopenia—Epirubicin—bone cancer	2.09e-05	0.000355	CcSEcCtD
Paclitaxel—Hypertension—Doxorubicin—bone cancer	2.09e-05	0.000355	CcSEcCtD
Paclitaxel—Tachycardia—Epirubicin—bone cancer	2.08e-05	0.000354	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Methotrexate—bone cancer	2.08e-05	0.000353	CcSEcCtD
Paclitaxel—Skin disorder—Epirubicin—bone cancer	2.07e-05	0.000352	CcSEcCtD
Paclitaxel—Hyperhidrosis—Epirubicin—bone cancer	2.06e-05	0.00035	CcSEcCtD
Paclitaxel—Insomnia—Methotrexate—bone cancer	2.06e-05	0.00035	CcSEcCtD
Paclitaxel—Myalgia—Doxorubicin—bone cancer	2.06e-05	0.00035	CcSEcCtD
Paclitaxel—Arthralgia—Doxorubicin—bone cancer	2.06e-05	0.00035	CcSEcCtD
Paclitaxel—Chest pain—Doxorubicin—bone cancer	2.06e-05	0.00035	CcSEcCtD
Paclitaxel—Anxiety—Doxorubicin—bone cancer	2.05e-05	0.000349	CcSEcCtD
Paclitaxel—Paraesthesia—Methotrexate—bone cancer	2.05e-05	0.000348	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	2.04e-05	0.000347	CcSEcCtD
Paclitaxel—ABCC10—tendon—bone cancer	2.04e-05	0.0169	CbGeAlD
Paclitaxel—Discomfort—Doxorubicin—bone cancer	2.03e-05	0.000346	CcSEcCtD
Paclitaxel—Anorexia—Epirubicin—bone cancer	2.03e-05	0.000346	CcSEcCtD
Paclitaxel—Dyspnoea—Methotrexate—bone cancer	2.03e-05	0.000345	CcSEcCtD
Paclitaxel—Somnolence—Methotrexate—bone cancer	2.03e-05	0.000344	CcSEcCtD
Paclitaxel—TUBB4B—tendon—bone cancer	2.02e-05	0.0167	CbGeAlD
Paclitaxel—Dry mouth—Doxorubicin—bone cancer	2.01e-05	0.000342	CcSEcCtD
Paclitaxel—Dyspepsia—Methotrexate—bone cancer	2.01e-05	0.000341	CcSEcCtD
Paclitaxel—Hypotension—Epirubicin—bone cancer	1.99e-05	0.000339	CcSEcCtD
Paclitaxel—Confusional state—Doxorubicin—bone cancer	1.99e-05	0.000338	CcSEcCtD
Paclitaxel—Decreased appetite—Methotrexate—bone cancer	1.98e-05	0.000337	CcSEcCtD
Paclitaxel—ABCC10—bone marrow—bone cancer	1.97e-05	0.0163	CbGeAlD
Paclitaxel—Oedema—Doxorubicin—bone cancer	1.97e-05	0.000335	CcSEcCtD
Paclitaxel—Anaphylactic shock—Doxorubicin—bone cancer	1.97e-05	0.000335	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Methotrexate—bone cancer	1.97e-05	0.000334	CcSEcCtD
Paclitaxel—ABCC10—spinal cord—bone cancer	1.97e-05	0.0163	CbGeAlD
Paclitaxel—Fatigue—Methotrexate—bone cancer	1.96e-05	0.000334	CcSEcCtD
Paclitaxel—TUBB4B—bone marrow—bone cancer	1.96e-05	0.0162	CbGeAlD
Paclitaxel—Infection—Doxorubicin—bone cancer	1.96e-05	0.000333	CcSEcCtD
Paclitaxel—TUBB4B—spinal cord—bone cancer	1.95e-05	0.0161	CbGeAlD
Paclitaxel—Pain—Methotrexate—bone cancer	1.95e-05	0.000331	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Epirubicin—bone cancer	1.94e-05	0.00033	CcSEcCtD
Paclitaxel—Shock—Doxorubicin—bone cancer	1.94e-05	0.00033	CcSEcCtD
Paclitaxel—Nervous system disorder—Doxorubicin—bone cancer	1.93e-05	0.000329	CcSEcCtD
Paclitaxel—Thrombocytopenia—Doxorubicin—bone cancer	1.93e-05	0.000328	CcSEcCtD
Paclitaxel—Insomnia—Epirubicin—bone cancer	1.93e-05	0.000328	CcSEcCtD
Paclitaxel—Tachycardia—Doxorubicin—bone cancer	1.93e-05	0.000327	CcSEcCtD
Paclitaxel—Skin disorder—Doxorubicin—bone cancer	1.92e-05	0.000326	CcSEcCtD
Paclitaxel—Paraesthesia—Epirubicin—bone cancer	1.91e-05	0.000326	CcSEcCtD
Paclitaxel—Hyperhidrosis—Doxorubicin—bone cancer	1.91e-05	0.000324	CcSEcCtD
Paclitaxel—TUBB2B—Metabolism of proteins—EIF2S1—bone cancer	1.9e-05	0.000339	CbGpPWpGaD
Paclitaxel—TUBB6—Metabolism of proteins—EIF2S1—bone cancer	1.9e-05	0.000339	CbGpPWpGaD
Paclitaxel—Dyspnoea—Epirubicin—bone cancer	1.9e-05	0.000323	CcSEcCtD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	1.9e-05	0.000338	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	1.9e-05	0.000338	CbGpPWpGaD
Paclitaxel—CYP3A7—Biological oxidations—CYP3A4—bone cancer	1.9e-05	0.000338	CbGpPWpGaD
Paclitaxel—Somnolence—Epirubicin—bone cancer	1.9e-05	0.000322	CcSEcCtD
Paclitaxel—ABCG2—Fluoropyrimidine Activity—TP53—bone cancer	1.89e-05	0.000337	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—MDM2—bone cancer	1.88e-05	0.000335	CbGpPWpGaD
Paclitaxel—Anorexia—Doxorubicin—bone cancer	1.88e-05	0.00032	CcSEcCtD
Paclitaxel—Feeling abnormal—Methotrexate—bone cancer	1.88e-05	0.000319	CcSEcCtD
Paclitaxel—Dyspepsia—Epirubicin—bone cancer	1.88e-05	0.000319	CcSEcCtD
Paclitaxel—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	1.87e-05	0.000333	CbGpPWpGaD
Paclitaxel—CYP19A1—Biological oxidations—GSTP1—bone cancer	1.87e-05	0.000333	CbGpPWpGaD
Paclitaxel—Gastrointestinal pain—Methotrexate—bone cancer	1.86e-05	0.000317	CcSEcCtD
Paclitaxel—Decreased appetite—Epirubicin—bone cancer	1.85e-05	0.000315	CcSEcCtD
Paclitaxel—SLCO1B3—Metabolism—NDUFA12—bone cancer	1.85e-05	0.000328	CbGpPWpGaD
Paclitaxel—CYP19A1—Metapathway biotransformation—GSTP1—bone cancer	1.84e-05	0.000328	CbGpPWpGaD
Paclitaxel—Hypotension—Doxorubicin—bone cancer	1.84e-05	0.000313	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Epirubicin—bone cancer	1.84e-05	0.000313	CcSEcCtD
Paclitaxel—Fatigue—Epirubicin—bone cancer	1.84e-05	0.000313	CcSEcCtD
Paclitaxel—TUBB3—Metabolism of proteins—EIF2S1—bone cancer	1.84e-05	0.000327	CbGpPWpGaD
Paclitaxel—Constipation—Epirubicin—bone cancer	1.82e-05	0.00031	CcSEcCtD
Paclitaxel—Pain—Epirubicin—bone cancer	1.82e-05	0.00031	CcSEcCtD
Paclitaxel—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	1.82e-05	0.000324	CbGpPWpGaD
Paclitaxel—Urticaria—Methotrexate—bone cancer	1.81e-05	0.000308	CcSEcCtD
Paclitaxel—MAPT—MAPK Signaling Pathway—EGFR—bone cancer	1.81e-05	0.000321	CbGpPWpGaD
Paclitaxel—Body temperature increased—Methotrexate—bone cancer	1.8e-05	0.000306	CcSEcCtD
Paclitaxel—Abdominal pain—Methotrexate—bone cancer	1.8e-05	0.000306	CcSEcCtD
Paclitaxel—CYP1B1—Biological oxidations—GSTP1—bone cancer	1.8e-05	0.00032	CbGpPWpGaD
Paclitaxel—Musculoskeletal discomfort—Doxorubicin—bone cancer	1.8e-05	0.000306	CcSEcCtD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—DHFR—bone cancer	1.79e-05	0.000319	CbGpPWpGaD
Paclitaxel—Insomnia—Doxorubicin—bone cancer	1.78e-05	0.000303	CcSEcCtD
Paclitaxel—TUBB2A—Metabolism of proteins—EIF2S1—bone cancer	1.78e-05	0.000317	CbGpPWpGaD
Paclitaxel—CYP1B1—Metapathway biotransformation—GSTP1—bone cancer	1.78e-05	0.000316	CbGpPWpGaD
Paclitaxel—Paraesthesia—Doxorubicin—bone cancer	1.77e-05	0.000301	CcSEcCtD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—MDM2—bone cancer	1.77e-05	0.000315	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—CHEK2—bone cancer	1.77e-05	0.000314	CbGpPWpGaD
Paclitaxel—Dyspnoea—Doxorubicin—bone cancer	1.76e-05	0.000299	CcSEcCtD
Paclitaxel—BCL2—Focal Adhesion—BRAF—bone cancer	1.76e-05	0.000313	CbGpPWpGaD
Paclitaxel—Feeling abnormal—Epirubicin—bone cancer	1.76e-05	0.000299	CcSEcCtD
Paclitaxel—Somnolence—Doxorubicin—bone cancer	1.75e-05	0.000298	CcSEcCtD
Paclitaxel—TUBB4A—Cell Cycle—DHFR—bone cancer	1.75e-05	0.000311	CbGpPWpGaD
Paclitaxel—Gastrointestinal pain—Epirubicin—bone cancer	1.74e-05	0.000296	CcSEcCtD
Paclitaxel—TUBB1—Metabolism of proteins—EIF2S1—bone cancer	1.74e-05	0.00031	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—NDUFA12—bone cancer	1.74e-05	0.000309	CbGpPWpGaD
Paclitaxel—Dyspepsia—Doxorubicin—bone cancer	1.74e-05	0.000295	CcSEcCtD
Paclitaxel—Decreased appetite—Doxorubicin—bone cancer	1.71e-05	0.000292	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Doxorubicin—bone cancer	1.7e-05	0.00029	CcSEcCtD
Paclitaxel—Fatigue—Doxorubicin—bone cancer	1.7e-05	0.000289	CcSEcCtD
Paclitaxel—Urticaria—Epirubicin—bone cancer	1.69e-05	0.000288	CcSEcCtD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.69e-05	0.0003	CbGpPWpGaD
Paclitaxel—Pain—Doxorubicin—bone cancer	1.69e-05	0.000287	CcSEcCtD
Paclitaxel—Constipation—Doxorubicin—bone cancer	1.69e-05	0.000287	CcSEcCtD
Paclitaxel—Abdominal pain—Epirubicin—bone cancer	1.69e-05	0.000287	CcSEcCtD
Paclitaxel—Body temperature increased—Epirubicin—bone cancer	1.69e-05	0.000287	CcSEcCtD
Paclitaxel—Hypersensitivity—Methotrexate—bone cancer	1.68e-05	0.000285	CcSEcCtD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.67e-05	0.000297	CbGpPWpGaD
Paclitaxel—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	1.66e-05	0.000296	CbGpPWpGaD
Paclitaxel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	1.65e-05	0.000294	CbGpPWpGaD
Paclitaxel—ABCG2—HIF-1-alpha transcription factor network—JUN—bone cancer	1.65e-05	0.000293	CbGpPWpGaD
Paclitaxel—ABCC2—tendon—bone cancer	1.64e-05	0.0135	CbGeAlD
Paclitaxel—Asthenia—Methotrexate—bone cancer	1.63e-05	0.000278	CcSEcCtD
Paclitaxel—BCL2—Direct p53 effectors—JUN—bone cancer	1.63e-05	0.000291	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.63e-05	0.00029	CbGpPWpGaD
Paclitaxel—Feeling abnormal—Doxorubicin—bone cancer	1.63e-05	0.000276	CcSEcCtD
Paclitaxel—CYP3A7—Biological oxidations—GSTP1—bone cancer	1.62e-05	0.000289	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—TP53—bone cancer	1.62e-05	0.000289	CbGpPWpGaD
Paclitaxel—MAPT—Apoptosis—TP53—bone cancer	1.62e-05	0.000288	CbGpPWpGaD
Paclitaxel—Gastrointestinal pain—Doxorubicin—bone cancer	1.61e-05	0.000274	CcSEcCtD
Paclitaxel—Pruritus—Methotrexate—bone cancer	1.61e-05	0.000274	CcSEcCtD
Paclitaxel—CYP1B1—tendon—bone cancer	1.6e-05	0.0133	CbGeAlD
Paclitaxel—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	1.6e-05	0.000285	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—DHFR—bone cancer	1.6e-05	0.000285	CbGpPWpGaD
Paclitaxel—Hypersensitivity—Epirubicin—bone cancer	1.57e-05	0.000267	CcSEcCtD
Paclitaxel—Urticaria—Doxorubicin—bone cancer	1.57e-05	0.000266	CcSEcCtD
Paclitaxel—TUBB4A—Metabolism of proteins—EIF2S1—bone cancer	1.56e-05	0.000278	CbGpPWpGaD
Paclitaxel—Body temperature increased—Doxorubicin—bone cancer	1.56e-05	0.000265	CcSEcCtD
Paclitaxel—Abdominal pain—Doxorubicin—bone cancer	1.56e-05	0.000265	CcSEcCtD
Paclitaxel—Diarrhoea—Methotrexate—bone cancer	1.56e-05	0.000265	CcSEcCtD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—JUN—bone cancer	1.54e-05	0.000274	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—EIF2S1—bone cancer	1.53e-05	0.000273	CbGpPWpGaD
Paclitaxel—Asthenia—Epirubicin—bone cancer	1.53e-05	0.00026	CcSEcCtD
Paclitaxel—SLCO1B3—Metabolism—NT5C3A—bone cancer	1.53e-05	0.000272	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis Modulation and Signaling—TP53—bone cancer	1.52e-05	0.000271	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—TP53—bone cancer	1.52e-05	0.00027	CbGpPWpGaD
Paclitaxel—Pruritus—Epirubicin—bone cancer	1.51e-05	0.000256	CcSEcCtD
Paclitaxel—Dizziness—Methotrexate—bone cancer	1.51e-05	0.000256	CcSEcCtD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—CDK4—bone cancer	1.5e-05	0.000268	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—BRCA2—bone cancer	1.5e-05	0.000266	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.47e-05	0.000261	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	1.47e-05	0.000261	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—CHEK2—bone cancer	1.46e-05	0.00026	CbGpPWpGaD
Paclitaxel—Diarrhoea—Epirubicin—bone cancer	1.46e-05	0.000248	CcSEcCtD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.46e-05	0.000259	CbGpPWpGaD
Paclitaxel—Hypersensitivity—Doxorubicin—bone cancer	1.45e-05	0.000247	CcSEcCtD
Paclitaxel—Vomiting—Methotrexate—bone cancer	1.45e-05	0.000246	CcSEcCtD
Paclitaxel—ABCC1—tendon—bone cancer	1.44e-05	0.0119	CbGeAlD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.44e-05	0.000256	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—NT5C3A—bone cancer	1.44e-05	0.000256	CbGpPWpGaD
Paclitaxel—Rash—Methotrexate—bone cancer	1.44e-05	0.000244	CcSEcCtD
Paclitaxel—Dermatitis—Methotrexate—bone cancer	1.44e-05	0.000244	CcSEcCtD
Paclitaxel—TUBB4B—Metabolism of proteins—EIF2S1—bone cancer	1.43e-05	0.000254	CbGpPWpGaD
Paclitaxel—Headache—Methotrexate—bone cancer	1.43e-05	0.000243	CcSEcCtD
Paclitaxel—Asthenia—Doxorubicin—bone cancer	1.42e-05	0.000241	CcSEcCtD
Paclitaxel—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	1.42e-05	0.000252	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	1.41e-05	0.000252	CbGpPWpGaD
Paclitaxel—Dizziness—Epirubicin—bone cancer	1.41e-05	0.00024	CcSEcCtD
Paclitaxel—Pruritus—Doxorubicin—bone cancer	1.4e-05	0.000237	CcSEcCtD
Paclitaxel—CYP3A5—Biological oxidations—CYP3A4—bone cancer	1.37e-05	0.000244	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.37e-05	0.000244	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—TP53—bone cancer	1.36e-05	0.000242	CbGpPWpGaD
Paclitaxel—Vomiting—Epirubicin—bone cancer	1.36e-05	0.00023	CcSEcCtD
Paclitaxel—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	1.35e-05	0.000241	CbGpPWpGaD
Paclitaxel—Nausea—Methotrexate—bone cancer	1.35e-05	0.00023	CcSEcCtD
Paclitaxel—BCL2—Innate Immune System—ATF1—bone cancer	1.35e-05	0.00024	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	1.35e-05	0.00024	CbGpPWpGaD
Paclitaxel—Diarrhoea—Doxorubicin—bone cancer	1.35e-05	0.00023	CcSEcCtD
Paclitaxel—Rash—Epirubicin—bone cancer	1.34e-05	0.000229	CcSEcCtD
Paclitaxel—Dermatitis—Epirubicin—bone cancer	1.34e-05	0.000228	CcSEcCtD
Paclitaxel—TUBB4B—Cell Cycle—CHEK2—bone cancer	1.34e-05	0.000238	CbGpPWpGaD
Paclitaxel—Headache—Epirubicin—bone cancer	1.34e-05	0.000227	CcSEcCtD
Paclitaxel—NR1I2—Gene Expression—EZH2—bone cancer	1.33e-05	0.000237	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—BRAF—bone cancer	1.33e-05	0.000237	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—TP53—bone cancer	1.32e-05	0.000235	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—NDUFA12—bone cancer	1.31e-05	0.000233	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—RB1—bone cancer	1.31e-05	0.000233	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—NDUFA12—bone cancer	1.3e-05	0.000232	CbGpPWpGaD
Paclitaxel—Dizziness—Doxorubicin—bone cancer	1.3e-05	0.000222	CcSEcCtD
Paclitaxel—BCL2—Direct p53 effectors—EGFR—bone cancer	1.29e-05	0.000229	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—JUN—bone cancer	1.28e-05	0.000228	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.27e-05	0.000227	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.27e-05	0.000226	CbGpPWpGaD
Paclitaxel—Nausea—Epirubicin—bone cancer	1.27e-05	0.000215	CcSEcCtD
Paclitaxel—CYP1B1—Metabolism—NDUFA12—bone cancer	1.26e-05	0.000225	CbGpPWpGaD
Paclitaxel—Vomiting—Doxorubicin—bone cancer	1.25e-05	0.000213	CcSEcCtD
Paclitaxel—Rash—Doxorubicin—bone cancer	1.24e-05	0.000211	CcSEcCtD
Paclitaxel—Dermatitis—Doxorubicin—bone cancer	1.24e-05	0.000211	CcSEcCtD
Paclitaxel—TUBB—Cell Cycle, Mitotic—CDK4—bone cancer	1.24e-05	0.000221	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—BRCA2—bone cancer	1.24e-05	0.000221	CbGpPWpGaD
Paclitaxel—Headache—Doxorubicin—bone cancer	1.24e-05	0.00021	CcSEcCtD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—EGFR—bone cancer	1.21e-05	0.000215	CbGpPWpGaD
Paclitaxel—CYP2C8—Biological oxidations—CYP3A4—bone cancer	1.19e-05	0.000212	CbGpPWpGaD
Paclitaxel—CYP3A5—Biological oxidations—GSTP1—bone cancer	1.17e-05	0.000209	CbGpPWpGaD
Paclitaxel—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	1.17e-05	0.000209	CbGpPWpGaD
Paclitaxel—Nausea—Doxorubicin—bone cancer	1.17e-05	0.000199	CcSEcCtD
Paclitaxel—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	1.16e-05	0.000206	CbGpPWpGaD
Paclitaxel—ABCG2—bone marrow—bone cancer	1.16e-05	0.00957	CbGeAlD
Paclitaxel—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	1.15e-05	0.000205	CbGpPWpGaD
Paclitaxel—ABCG2—spinal cord—bone cancer	1.15e-05	0.00952	CbGeAlD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	1.15e-05	0.000204	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—NDUFA12—bone cancer	1.15e-05	0.000204	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—NDUFA12—bone cancer	1.14e-05	0.000203	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—BRCA2—bone cancer	1.13e-05	0.000202	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—MDM2—bone cancer	1.12e-05	0.000198	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—CDK4—bone cancer	1.11e-05	0.000197	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—NT5C3A—bone cancer	1.09e-05	0.000193	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—NT5C3A—bone cancer	1.08e-05	0.000192	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle, Mitotic—RB1—bone cancer	1.08e-05	0.000192	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—TP53—bone cancer	1.08e-05	0.000192	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	1.05e-05	0.000186	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—NT5C3A—bone cancer	1.05e-05	0.000186	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—CDK4—bone cancer	1.03e-05	0.000183	CbGpPWpGaD
Paclitaxel—CYP2C8—Biological oxidations—GSTP1—bone cancer	1.02e-05	0.000181	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—TP53—bone cancer	1.02e-05	0.000181	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—EGFR—bone cancer	1.01e-05	0.000179	CbGpPWpGaD
Paclitaxel—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	1e-05	0.000178	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1e-05	0.000178	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—TP53—bone cancer	9.95e-06	0.000177	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—JUN—bone cancer	9.69e-06	0.000172	CbGpPWpGaD
Paclitaxel—CYP2C9—Biological oxidations—CYP3A4—bone cancer	9.67e-06	0.000172	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—RB1—bone cancer	9.65e-06	0.000172	CbGpPWpGaD
Paclitaxel—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	9.54e-06	0.00017	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	9.52e-06	0.000169	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—NT5C3A—bone cancer	9.51e-06	0.000169	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—NT5C3A—bone cancer	9.43e-06	0.000168	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—CDK4—bone cancer	9.41e-06	0.000167	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	9.39e-06	0.000167	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—CDK4—bone cancer	9.19e-06	0.000164	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—RB1—bone cancer	8.94e-06	0.000159	CbGpPWpGaD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	8.9e-06	0.000158	CbGpPWpGaD
Paclitaxel—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	8.42e-06	0.00015	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	8.42e-06	0.00015	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—CDK4—bone cancer	8.41e-06	0.00015	CbGpPWpGaD
Paclitaxel—CYP2C9—Biological oxidations—GSTP1—bone cancer	8.27e-06	0.000147	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—MDM2—bone cancer	8.23e-06	0.000146	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—NDUFA12—bone cancer	8.23e-06	0.000146	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—RB1—bone cancer	8.18e-06	0.000146	CbGpPWpGaD
Paclitaxel—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	8.16e-06	0.000145	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—RB1—bone cancer	7.99e-06	0.000142	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	7.96e-06	0.000142	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.94e-06	0.000141	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—ATF1—bone cancer	7.87e-06	0.00014	CbGpPWpGaD
Paclitaxel—TUBB2B—Metabolism of proteins—MMP2—bone cancer	7.79e-06	0.000139	CbGpPWpGaD
Paclitaxel—TUBB6—Metabolism of proteins—MMP2—bone cancer	7.79e-06	0.000139	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—KIT—bone cancer	7.69e-06	0.000137	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL3—bone cancer	7.68e-06	0.000137	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—EGFR—bone cancer	7.62e-06	0.000136	CbGpPWpGaD
Paclitaxel—TUBB3—Metabolism of proteins—MMP2—bone cancer	7.52e-06	0.000134	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—RB1—bone cancer	7.31e-06	0.00013	CbGpPWpGaD
Paclitaxel—TUBB2A—Metabolism of proteins—MMP2—bone cancer	7.28e-06	0.00013	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—NDUFA12—bone cancer	7.12e-06	0.000127	CbGpPWpGaD
Paclitaxel—TUBB1—Metabolism of proteins—MMP2—bone cancer	7.12e-06	0.000127	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.85e-06	0.000122	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—MDM2—bone cancer	6.82e-06	0.000121	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—NT5C3A—bone cancer	6.82e-06	0.000121	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—ENO2—bone cancer	6.7e-06	0.000119	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—TP53—bone cancer	6.4e-06	0.000114	CbGpPWpGaD
Paclitaxel—TUBB4A—Metabolism of proteins—MMP2—bone cancer	6.39e-06	0.000114	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—ENO2—bone cancer	6.3e-06	0.000112	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—MDM2—bone cancer	6.23e-06	0.000111	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—DHFR—bone cancer	6.21e-06	0.000111	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—NDUFA12—bone cancer	6.21e-06	0.00011	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—MDM2—bone cancer	6.06e-06	0.000108	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	5.9e-06	0.000105	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—NT5C3A—bone cancer	5.9e-06	0.000105	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—DHFR—bone cancer	5.85e-06	0.000104	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—MMP2—bone cancer	5.85e-06	0.000104	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—GNA11—bone cancer	5.81e-06	0.000103	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NDUFA12—bone cancer	5.8e-06	0.000103	CbGpPWpGaD
Paclitaxel—ABCB1—bone marrow—bone cancer	5.7e-06	0.00472	CbGeAlD
Paclitaxel—ABCB1—spinal cord—bone cancer	5.68e-06	0.0047	CbGeAlD
Paclitaxel—ABCC1—Disease—ENO2—bone cancer	5.65e-06	0.000101	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—GNA11—bone cancer	5.47e-06	9.73e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.46e-06	9.71e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5.38e-06	9.58e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—CYP3A4—bone cancer	5.27e-06	9.37e-05	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—JUN—bone cancer	5.26e-06	9.37e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—DHFR—bone cancer	5.25e-06	9.33e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.24e-06	9.32e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—NT5C3A—bone cancer	5.14e-06	9.15e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—CYP3A4—bone cancer	4.96e-06	8.82e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	4.93e-06	8.77e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NT5C3A—bone cancer	4.8e-06	8.55e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ENO2—bone cancer	4.76e-06	8.46e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ENO2—bone cancer	4.74e-06	8.43e-05	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—TP53—bone cancer	4.72e-06	8.4e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ENO2—bone cancer	4.58e-06	8.15e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—GSTP1—bone cancer	4.5e-06	8.01e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—KIT—bone cancer	4.48e-06	7.97e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—DHFR—bone cancer	4.41e-06	7.85e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—DHFR—bone cancer	4.39e-06	7.82e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.38e-06	7.79e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—DHFR—bone cancer	4.25e-06	7.56e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—GSTP1—bone cancer	4.24e-06	7.54e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	4.22e-06	7.51e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ENO2—bone cancer	4.17e-06	7.42e-05	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—EGFR—bone cancer	4.14e-06	7.37e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ENO2—bone cancer	4.13e-06	7.35e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—GNA11—bone cancer	4.12e-06	7.34e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—GNA11—bone cancer	4.11e-06	7.31e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—GNA11—bone cancer	3.97e-06	7.07e-05	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—TP53—bone cancer	3.91e-06	6.96e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—DHFR—bone cancer	3.87e-06	6.88e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—DHFR—bone cancer	3.83e-06	6.82e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NDUFA12—bone cancer	3.82e-06	6.81e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.8e-06	6.77e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TGFBR2—bone cancer	3.8e-06	6.76e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CYP3A4—bone cancer	3.74e-06	6.65e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CYP3A4—bone cancer	3.72e-06	6.62e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.72e-06	6.62e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.7e-06	6.59e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—GNA11—bone cancer	3.61e-06	6.43e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CYP3A4—bone cancer	3.6e-06	6.41e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.58e-06	6.37e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—GNA11—bone cancer	3.58e-06	6.37e-05	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—TP53—bone cancer	3.58e-06	6.37e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—MDM2—bone cancer	3.53e-06	6.28e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CYP3A4—bone cancer	3.28e-06	5.83e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CYP3A4—bone cancer	3.25e-06	5.78e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—GSTP1—bone cancer	3.2e-06	5.69e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—GSTP1—bone cancer	3.18e-06	5.67e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NT5C3A—bone cancer	3.17e-06	5.64e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—GSTP1—bone cancer	3.08e-06	5.48e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—JUN—bone cancer	3.07e-06	5.46e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.99e-06	5.32e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ENO2—bone cancer	2.99e-06	5.31e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—GSTP1—bone cancer	2.8e-06	4.99e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—GSTP1—bone cancer	2.78e-06	4.94e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—DHFR—bone cancer	2.77e-06	4.93e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—KIT—bone cancer	2.59e-06	4.62e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GNA11—bone cancer	2.59e-06	4.61e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ENO2—bone cancer	2.59e-06	4.6e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.51e-06	4.47e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—BRAF—bone cancer	2.44e-06	4.34e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—EGFR—bone cancer	2.41e-06	4.29e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—DHFR—bone cancer	2.4e-06	4.27e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP3A4—bone cancer	2.35e-06	4.18e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PTGS2—bone cancer	2.33e-06	4.15e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ENO2—bone cancer	2.25e-06	4.01e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GNA11—bone cancer	2.24e-06	3.99e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PTGS2—bone cancer	2.2e-06	3.91e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ENO2—bone cancer	2.1e-06	3.75e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—DHFR—bone cancer	2.09e-06	3.72e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MDM2—bone cancer	2.04e-06	3.64e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP3A4—bone cancer	2.03e-06	3.62e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.02e-06	3.6e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GSTP1—bone cancer	2.01e-06	3.57e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTGS2—bone cancer	1.97e-06	3.5e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GNA11—bone cancer	1.95e-06	3.48e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—DHFR—bone cancer	1.95e-06	3.47e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GNA11—bone cancer	1.82e-06	3.25e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP3A4—bone cancer	1.77e-06	3.15e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GSTP1—bone cancer	1.74e-06	3.09e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PTGS2—bone cancer	1.66e-06	2.95e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP3A4—bone cancer	1.65e-06	2.94e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PTGS2—bone cancer	1.65e-06	2.94e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.65e-06	2.93e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PTGS2—bone cancer	1.6e-06	2.84e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GSTP1—bone cancer	1.51e-06	2.7e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTGS2—bone cancer	1.45e-06	2.58e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTGS2—bone cancer	1.44e-06	2.56e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTP1—bone cancer	1.41e-06	2.52e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—EGFR—bone cancer	1.4e-06	2.48e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ENO2—bone cancer	1.39e-06	2.47e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—DHFR—bone cancer	1.29e-06	2.29e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GNA11—bone cancer	1.2e-06	2.14e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTGS2—bone cancer	1.04e-06	1.85e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTP1—bone cancer	9.33e-07	1.66e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTGS2—bone cancer	9.01e-07	1.6e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTGS2—bone cancer	7.85e-07	1.4e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTGS2—bone cancer	7.33e-07	1.3e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTGS2—bone cancer	4.83e-07	8.6e-06	CbGpPWpGaD
